BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260413
DTEND;VALUE=DATE:20260415
DTSTAMP:20260608T042044
CREATED:20251212T172218Z
LAST-MODIFIED:20251212T172933Z
UID:9644-1776038400-1776211199@thebiocalendar.com
SUMMARY:CMO Summit 360°
DESCRIPTION:The Largest ​​​​​​​Annual Gathering of Biotech CMOs\n  \n\n\n\n\nThe 14th annual CMO Summit 360° ® is the largest gathering of biotech Chief Medical Officers across indications\, modalities\, company stages\, professional experience levels and geographic locations. This is the conference to connect with peers and develop the skills needed to succeed as a biotech CMO. \nWe are thrilled to announce that the CMO Summit 360° is now part of Fierce Life Sciences. Combining our resources allows for greater market reach\, more networking and partnering.
URL:https://thebiocalendar.com/event/cmo-summit-360-3/
LOCATION:Boston\, MA\, 02210\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260413
DTEND;VALUE=DATE:20260417
DTSTAMP:20260608T042044
CREATED:20260109T153145Z
LAST-MODIFIED:20260109T153146Z
UID:9756-1776038400-1776383999@thebiocalendar.com
SUMMARY:Drug Discovery Chemistry
DESCRIPTION:Drug Discovery Chemistry is a dynamic conference for medicinal\, biophysical\, and computational chemists working across pharma\, biotech\, and academia. Focused on discovery and optimization challenges of small-molecule and macrocyclic drug candidates\, the 2026 event features new sessions spanning AI- and ML-driven design\, fragment- and structure-based discovery\, molecular glues and degraders\, DNA-encoded libraries\, and emerging biophysical tools. Attendees can tailor their experience by exploring concurrent tracks covering today’s most innovative approaches to drug discovery.
URL:https://thebiocalendar.com/event/drug-discovery-chemistry-2/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260414
DTEND;VALUE=DATE:20260416
DTSTAMP:20260608T042044
CREATED:20251125T143235Z
LAST-MODIFIED:20251125T143235Z
UID:9584-1776124800-1776297599@thebiocalendar.com
SUMMARY:American Biomanufacturing Summit
DESCRIPTION:The Generis American Biomanufacturing Summit (BIO) has a strong reputation as the leading platform for connecting senior leaders and exchanging ideas in the biopharma and biotech industries. This two-day conference is designed to bring together biopharma executives and solution providers to discuss emerging trends\, strategic insights\, and best practices in an ever-evolving biomanufacturing landscape. Join over 350 biopharma and biotech executive leaders\, including more than 50 speakers\, 150 senior-level attendees\, and hundreds of participants from solution companies at this annual event as we explore the latest challenges\, opportunities\, and innovations shaping the industry. With sessions led by top biotech executives\, the agenda will dive into critical topics such as AAV manufacturing\, cell and gene therapy\, capacity management\, quality assurance and control\, regulatory compliance\, operational excellence\, and supply chain and logistics. Network with fellow biopharma leaders and connect with leading solution providers as we uncover strategies to maximize efficiency and ensure compliance within the biomanufacturing space.
URL:https://thebiocalendar.com/event/american-biomanufacturing-summit/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260414T110000
DTEND;TZID=America/Los_Angeles:20260414T120000
DTSTAMP:20260608T042044
CREATED:20260310T161658Z
LAST-MODIFIED:20260310T161659Z
UID:10000-1776164400-1776168000@thebiocalendar.com
SUMMARY:Proactive Contamination Control in Aseptic Fill/Finish
DESCRIPTION:Join experts Herman Bozenhardt\, President of Bozenhardt Consulting\, and James Janachowski\, MS&T Site Lead\, Process Engineering for CSL Behring\, as they explore topics such as risk-based facility and equipment design\, advanced barrier technologies\, personnel and material flow optimization\, environmental monitoring trending and data analytics\, and the integration of rapid microbiological methods.
URL:https://thebiocalendar.com/event/proactive-contamination-control-in-aseptic-fill-finish/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/26_04-POL-Reg-1920x250-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260414T110000
DTEND;TZID=America/Los_Angeles:20260414T120000
DTSTAMP:20260608T042044
CREATED:20260313T114432Z
LAST-MODIFIED:20260313T114432Z
UID:10017-1776164400-1776168000@thebiocalendar.com
SUMMARY:Turbocharge CAR-T Manufacturing: Industrializing Cell Therapy with Perfusion
DESCRIPTION:As the field transitions toward scalable\, cost-efficient allogeneic CAR-T therapies\, manufacturing intensification is no longer optional\, it is essential. \nThis webinar demonstrates how perfusion using XCell® ATF technology enables rapid\, high-density CAR-T expansion in stirred-tank bioreactors while preserving critical quality attributes. Data from intensified 2 L perfusion processes show consistent production of >110 anti-CD19 CAR-T doses within a 12-day manufacturing cycle\, using serum-free media and optimized perfusion strategies. \nWe will present predictive scale-down modeling from Ambr® 250 STR to 2 L scale\, stable process control with matched volumetric power input (P/V)\, and real-time viable cell monitoring using multi-frequency capacitance. We will also cover seamless downstream integration with automated harvest systems such as Ksep®\, achieving >90% recovery. Attendees will gain practical insight into how perfusion using XCell® ATF System reduces timelines\, increases yields\, improves process control\, and establishes a scalable\, economically viable CAR-T manufacturing platform. \nKey Learning Objectives:\n~    How matched volumetric power input (P/V) enables predictive scale-down modeling and de-risked tech transfer from Ambr® 250 to 2 L scale\n~    Why XCell ATF perfusion delivers ~34% greater fold expansion than G-Rex® systems and how multi-frequency capacitance enables real-time viable cell density prediction\n~   How to integrate automated harvest systems (e.g.\, Ksep®) for >90% recovery in an industrialized allogeneic CAR-T workflow
URL:https://thebiocalendar.com/event/turbocharge-car-t-manufacturing-industrializing-cell-therapy-with-perfusion/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-14-26-Repligen-LinkedIn-1280x720-1.png
END:VEVENT
END:VCALENDAR